142 related articles for article (PubMed ID: 24663822)
21. [Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial].
Nijssen EC; Rennenberg RJ; Nelemans PJ; Essers BA; Janssen MM; Vermeeren MA; van Ommen V; Wildberger JE
Ned Tijdschr Geneeskd; 2018; 161():D1734. PubMed ID: 29328007
[TBL] [Abstract][Full Text] [Related]
22. Proteinuria and Reduced Estimated Glomerular Filtration Rate Are Independent Risk Factors for Contrast-Induced Nephropathy After Cardiac Catheterization.
Saito Y; Watanabe M; Aonuma K; Hirayama A; Tamaki N; Tsutsui H; Murohara T; Ogawa H; Akasaka T; Yoshimura M; Sato A; Takayama T; Sakakibara M; Suzuki S; Ishigami K; Onoue K;
Circ J; 2015; 79(7):1624-30. PubMed ID: 25891891
[TBL] [Abstract][Full Text] [Related]
23. Contrast nephropathy in cancer patients receiving anti-VEGF therapy: a prospective study.
Gökyer A; Küçükarda A; Köstek O; Hacıoğlu MB; Uzunoğlu S; Kula O; Kurt N; Üstündağ S; Erdoğan B; Çiçin İ
Int J Clin Oncol; 2020 Oct; 25(10):1757-1762. PubMed ID: 32591963
[TBL] [Abstract][Full Text] [Related]
24. Prediction of contrast-induced nephropathy in diabetics undergoing elective percutaneous coronary intervention: role of the ratio of contrast medium volume to estimated glomerular filtration rate.
Wang XC; Fu XH; Wang YB; Jia XW; Wu WL; Gu XS; Zhang J; Su JL; Hao GZ; Jiang YF; Fan WZ; Li SQ
Chin Med J (Engl); 2011 Mar; 124(6):892-6. PubMed ID: 21518598
[TBL] [Abstract][Full Text] [Related]
25. Contrast-induced nephropathy in patients undergoing computed tomography (CONNECT) - a clinical problem in daily practice? A multicenter observational study.
Lencioni R; Fattori R; Morana G; Stacul F
Acta Radiol; 2010 Sep; 51(7):741-50. PubMed ID: 20707658
[TBL] [Abstract][Full Text] [Related]
26. Contrast medium volume to estimated glomerular filtration rate ratio as a predictor of contrast-induced nephropathy developing after elective percutaneous coronary intervention.
Nozue T; Michishita I; Iwaki T; Mizuguchi I; Miura M
J Cardiol; 2009 Oct; 54(2):214-20. PubMed ID: 19782258
[TBL] [Abstract][Full Text] [Related]
27. Epidemiology of contrast material-induced nephropathy in the era of hydration.
Balemans CE; Reichert LJ; van Schelven BI; van den Brand JA; Wetzels JF
Radiology; 2012 Jun; 263(3):706-13. PubMed ID: 22535561
[TBL] [Abstract][Full Text] [Related]
28. Dosing of iodinated contrast volume: a new simple algorithm to stratify the risk of contrast-induced nephropathy in patients with acute coronary syndrome.
Raposeiras-Roubín S; Abu-Assi E; Ocaranza-Sánchez R; Alvarez-Álvarez B; Cambeiro-González C; Fandiño-Vaquero R; García-Castelo A; García-Acuña JM; González-Juanatey JR
Catheter Cardiovasc Interv; 2013 Nov; 82(6):888-97. PubMed ID: 23362013
[TBL] [Abstract][Full Text] [Related]
29. Contrast medium dose-to-GFR ratio: a measure of systemic exposure to predict contrast-induced nephropathy after percutaneous coronary intervention.
Nyman U; Björk J; Aspelin P; Marenzi G
Acta Radiol; 2008 Jul; 49(6):658-67. PubMed ID: 18568558
[TBL] [Abstract][Full Text] [Related]
30. Incidence and outcomes of contrast-induced nephropathy after computed tomography in patients with CKD: a quality improvement report.
Kim SM; Cha RH; Lee JP; Kim DK; Oh KH; Joo KW; Lim CS; Kim S; Kim YS
Am J Kidney Dis; 2010 Jun; 55(6):1018-25. PubMed ID: 20097462
[TBL] [Abstract][Full Text] [Related]
31. Iodixanol versus iopromide in cancer patients: Evidence from a randomized clinical trial.
Terrenato I; Sperati F; Musicco F; Pozzi AF; di Turi A; Caterino M; de Lutio di Castelguidone E; Setola SV; Bellomi M; Neumaier CE; Conti L; Cigliana G; Merola R; Antenucci A; Orlandi G; Giordano A; Barba M; Canitano S
J Cell Physiol; 2018 Mar; 233(3):2572-2580. PubMed ID: 28777459
[TBL] [Abstract][Full Text] [Related]
32. Patients at risk for contrast-induced nephropathy and mid-term effects after contrast administration: a prospective cohort study.
Moos SI; Nagan G; de Weijert RS; van Vemde DN; Stoker J; Bipat S
Neth J Med; 2014 Sep; 72(7):363-71. PubMed ID: 25178770
[TBL] [Abstract][Full Text] [Related]
33. Insulin Resistance Increases the Risk of Contrast-Induced Nephropathy in Patients Undergoing Elective Coronary Intervention.
Li Y; Liu Y; Shi D; Yang L; Liang J; Zhou Y
Angiology; 2016 Feb; 67(2):139-45. PubMed ID: 25843952
[TBL] [Abstract][Full Text] [Related]
34. Are intravenous injections of contrast media really less nephrotoxic than intra-arterial injections?
Nyman U; Almén T; Jacobsson B; Aspelin P
Eur Radiol; 2012 Jun; 22(6):1366-71. PubMed ID: 22307815
[TBL] [Abstract][Full Text] [Related]
35. Contrast-Induced Nephropathy After Computed Tomography in Stable CKD Patients With Proper Prophylaxis: 8-Year Experience of Outpatient Prophylaxis Program.
Park S; Kim MH; Kang E; Park S; Jo HA; Lee H; Kim SM; Lee JP; Oh KH; Joo KW; Kim YS; Kim DK
Medicine (Baltimore); 2016 May; 95(18):e3560. PubMed ID: 27149474
[TBL] [Abstract][Full Text] [Related]
36. Is there association between statin usage and contrast-associated acute kidney injury after intravenous administration of iodine-based contrast media in enhanced computed tomography?
Park JH; Shin HJ; Choi JY; Lim JS; Park MS; Kim MJ; Oh HJ; Chung YE
Eur Radiol; 2020 Oct; 30(10):5261-5271. PubMed ID: 32399711
[TBL] [Abstract][Full Text] [Related]
37. Computerized tomography contrast induced nephropathy (CIN) among adult inpatients.
Diogo LP; Bahlis LF; Carvalhal GF
J Bras Nefrol; 2014; 36(4):446-50. PubMed ID: 25517272
[TBL] [Abstract][Full Text] [Related]
38. Cancer surveillance imaging: Does repeated iodinated contrast exposure impact long-term kidney function?
Heinen J; Hsu M; Selby LV; Russo AE; Nash GM; Jaimes EA; Shingarev R
Clin Nephrol; 2020 Dec; 94(6):281-289. PubMed ID: 32870145
[TBL] [Abstract][Full Text] [Related]
39. Risk of contrast-induced nephropathy for patients receiving intravenous vs. intra-arterial iodixanol administration.
Tong GE; Kumar S; Chong KC; Shah N; Wong MJ; Zimmet JM; Wang ZJ; Yee J; Fu Y; Yeh BM
Abdom Radiol (NY); 2016 Jan; 41(1):91-9. PubMed ID: 26830615
[TBL] [Abstract][Full Text] [Related]
40. Cost of screening strategies for kidney disease before intravenous contrast administration.
Moos SI; de Weijert RS; Nagan G; Stoker J; Bipat S
Neth J Med; 2014 Jun; 72(5):271-80. PubMed ID: 24930461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
